Severe Legionnaires' disease successfully treated with levofloxacin and azithromycin [1]

Journal of Chemotherapy

Volumn 18, Issue 5, 2006, Pages 559-561

  Pedro Botet, M L ^a   Garcia Cruz A ^a   Tural, C ^a   Mateu, L ^a   Sopena, N ^a   Roure, S ^a   Rey Joly, C ^a   Sabria, M ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PAZUFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANAMNESIS; ARTIFICIAL VENTILATION; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG POTENTIATION; EARLY DIAGNOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LEGIONNAIRE DISEASE; LETTER; LUNG LAVAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33751199102     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.5.559     Document Type: Letter

References (19)

1. Sabrià M, Yu VL. Legionella species (Legionnaires' disease). In: Yu VL, Weber R, Raoult D, editors. Antimicrobial therapy and vaccines, 2nd edition. Apple Trees Productions, LLC. New York 2002: 395-417.
2. Pedro-Botet ML, Sabrià M, Sopena N, et al. Legionnaires' disease and HIV infection. Chest 2003; 124:543-47.
3. Pedro-Botet ML, Sabrià-Leal M, Sopena N, et al. Role of immunosuppression in the evolution of Legionnaires' disease. Clin Infect Dis 1998;26: 14-9.
4. Barker JE. Farrell ID. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies. J Antimicrob Chemother 1990;26;45-53.
5. Martin SJ, Pendland SL, Chen C, Schreckenberger PC, Danziguer LH. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella. Antimicrob Agents Chemother 1996; 40:1419-21.
6. Martin SJ, Pendland SL, Chen C, Schreckenberger PC, Danziguer LH. In vitro activity of clarithromycin alone and in combination with ciprofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. Diagn Microbiol Infect Dis 1997;29:167-71.
7. Moffie BG, Mouton RP. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics. J Antimicrob Chemother 1988;22:457-62.
8. Baltch AL, Smith RP, Franke MA, Michelsen PhB. Antibacterial effects of levofloxacin, erythromycin and rifampin in a human monocyte system against Legionella pneumophila. Antimicrob Agents Chemother 1998; 42:3153-6
9. Smith RP, Baltch AL, Franke M, Hioe W, Titz W, Michelsen P. Effect of levofioxacin, erythromycin or rifampicin pre-treatment on growth of Legionella pneumophila in human monocytes. J Antimicrob Chemother 1997; 40:673-8
10. Blazquez-Garrido RM, Espinosa Parra FJ, Alemany Francés L, et al. Antimicrobial chemotherapy for Legionnaires' disease: levofioxacin versus macrolides. Clin Infect Dis 2005; 40:800-6.
11. Mykietiuk A, Carratalà J, Fernández-Sabé N, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofioxacin therapy. Clin Infect Dis 2005; 40:794-9.
12. Sabrià M, Pedro-Botet ML, Gomez J, et al. For the Legionniares' disease therapy group. Fluoroquinolones versus macrolides in the treatment of Legionnaires' disease. Chest 2005; 128:1401-5.
13. Trubel HK, Meyer HG, Jahn B, Knuf M, Kamin W, Huth RG. Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child. Scand J Infect Dis 2002; 34:219-21
14. Stroup JS, Hendrickson SE, Neil M. Legionella pneumonia and HIV infection: a case report. AIDSRead 2004,14:267-71.
15. Ishii Y, Bando M, Ohno S, Sugiyama Y. A travel abroad-associated case of Legionella pneumonia diagnosed by urinary antigen detection test. Kansenshogaku Zasshi 2005; 79:290-3.
16. Oguma A, Kojima T, Himeji D, Arinobu Y, Kikuchi I, Ueda A. A case of Legionella pneumonia complicated with acute respiratory distress syndrome treated with methylprednisolone and silvelestat sodium in combination with intravenous erythromycin and ciprofloxacin. Nihon Kokyuki Gakkai Zasshi 2004; 42:956-60.
17. Okano Y, Motoki T, Miki M, et al. A case of Legionella pneumonia successfully treated intravenously with both erythromycin and ciprofloxacin. Nihon Kokyuki Gakkai Zasshi 2001; 39:949-54
18. Stout JE, Sens K, Mietzner S, Obman A, Yu VL. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing. Int J Antimicrob Agents 2005;25:302-7
19. Edelstein PH, Edelstein MAC. In vitro activity of azithromycin against clinical isolates of Legionella species. Antimicrob Agents Chemother 1991; 35:180-1.